Method and composition for treating tendon or joint inflammation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514947, A61K 3147

Patent

active

052781720

ABSTRACT:
A process is provided which is useful in alleviating inflammation of tendons and/or joints in a patient in need of such treatment. The process comprises administering a vasodilator to the inflamed tissue, either topically or by injection. Advantageously, the vasodilator is papaverine or a pharmaceutically acceptable salt thereof such as papaverine hydrochloride. Advantageously, the papaverine hydrochloride may be administered topically in a composition comprising a carrier. The carrier dissolves the papaverine hydrochloride and enables it to penetrate the skin and be absorbed into the inflamed tissue.

REFERENCES:
patent: 4018927 (1977-04-01), Voorhees
patent: 4440777 (1984-04-01), Zupan
patent: 4758433 (1988-07-01), Johnson et al.
patent: 5059603 (1991-10-01), Rubin
Batterman et al., Angiology 21(9), 1970, pp. 612-626.
Batterman et al., CA 74(1):2610a (Chemical Abstracts), 1970.
Matveikov et al., 89:185149 Biosis, BA87:96415, 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method and composition for treating tendon or joint inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for treating tendon or joint inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating tendon or joint inflammation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1631557

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.